CYTOKINETICS INC — Director's Dealing 2021

Nov 9, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2021-11-09

Reporting Person: Cragg David (Chief HR & Admin Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-09	Common Stock	M	24519	$9.65	Acquired	163223	Direct
2021-11-09	Common Stock	S	24519	$41.7602	Disposed	138704	Direct
2021-11-09	Common Stock	M	20481	$9.65	Acquired	159185	Direct
2021-11-09	Common Stock	S	20481	$41.7602	Disposed	138704	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-09	Incentive Stock Option (right to buy)	$9.65	M	20481	Disposed	2024-02-24	Common Stock (20481)	Direct
2021-11-09	Non-Qualified Stock Option (right to buy)	$9.65	M	24519	Disposed	2024-02-24	Common Stock (24519)	Direct

Footnotes

F1: Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan.